Experiments were performed in the longitudinal muscle strip of the gui
nea pig ileum to characterize the receptors involved in the contractil
e response of this preparation to neurokinins. Antagonists for the NK-
1 (CP 96345, CP 99994) and NK-2 (SR 48968) receptors, atropine for NK-
3 receptors, as well as diphenhydramine (histamine H-1 receptor antago
nist) and indometacin (cyclooxygenase inhibitor) were used to determin
e the relative contribution of neurokinin receptors and some endogenou
s agents to the myotropic effects of substance P (SP) and neurokinin r
eceptor selective agonists. The present findings indicate that the thr
ee neurokinin receptor types take part in the contractile activities o
f SP-related peptides. NK-1 receptors, probably localized in the smoot
h muscle, are inhibited only by the two CP compounds and not by atropi
ne or the other agents. NK-2 receptors contribute to the contraction b
y 5-10% and are blocked by SR 48968. NK-3 receptors act indirectly thr
ough the release of acetylcholine from the myenteric plexus, since act
ivities of [MePhe(7)]NKB and senktide are blocked by atropine. Septide
behaves as a selective NK-1 receptor agonist and does not show any di
fference with SP, except for higher sensitivity to CP antagonists. The
same is observed with Ac[Arg(6),Sar(9),Met(O-2)(11)]SP(6-11), another
NK-1-selective fragment. Discrepancies between antagonist pA(2) value
s obtained against undeca- and hexapeptide agonists are interpreted as
due to a stronger binding affinity of undecapeptide agonists as compa
red with the hexapeptides. Results of binding assays confirm data from
the literature by showing that undecapeptide agonists have higher aff
inities than hexapeptides, particularly septide, and such discrepancie
s (with the biological assays) can also be explained by the reduction
or absence of the cationic charge at the N terminal of septide.